Kite Pharma, Inc.: intangible_assets
| Value | {"amount": 10762000, "concept": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "currency": "USD"} |
|---|---|
| Period | (as of 2016-03-31) |
| Status | current |
| Entity | Kite Pharma, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/88d7f8b7-7c3f-4b9d-bf87-ae4e3354055c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-16-018576 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510580/intangible-assets/2016-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/88d7f8b7-7c3f-4b9d-bf87-ae4e3354055c
History
- no predecessors — first report